EMA has published a draft reflection paper
outlining the current thinking on the use of artificial intelligence
(AI) to support the safe and effective development, regulation and use
of human and veterinary medicines. This paper, which is now open for
public consultation, reflects on principles relevant to the application
of AI and machine learning (ML) at any step of a medicines’ lifecycle,
from drug discovery to the post-authorisation setting. (...)
The deceptively negotiable Donald Trump
-
The tariff row is further indication that he is quick to quarrel but also
quick to settle
2 ore fa
Post
Nessun commento:
Posta un commento